Know your dog’s risk for developing mast cell tumors

Embark now offers a new way to estimate a dog’s risk for developing mast cell tumors (MCT), based on their genetics and other factors. Knowing your dog’s risk can help you give them proactive care.

Get exclusive early access to our MCT risk estimate for $20

What is MCT risk?

Mast cell tumors, the most common type of malignant skin tumor in dogs, are highly treatable if caught early. Knowing your dog’s MCT risk can help you (and your veterinarian) monitor their health.

With our MCT risk estimate, you can:

  • Learn your dog’s unique genetic risk for developing MCT
  • Understand the signs to look for
  • Know when to seek veterinary care

Join the waitlist

The science behind MCT risk

Any dog can develop a mast cell tumor, but some breeds (and breed mixes) are more susceptible than others. The exact cause may be due to a variety of genetic and environmental factors.

Our risk model analyzes:

  • Your dog’s unique genetic breed ancestry
  • Certain genetic markers associated with MCT
  • Age, sex, and other factors

Affected Breeds

Dogs who may have increased risk include:

  • Alapaha Blue Blood Bulldog
  • American Bulldog
  • American Bully
  • American Pit Bull Terrier
  • American Staffordshire Terrier
  • Boston Terrier
  • Boxer
  • Bull Terrier, Bulldog (English Bulldog)
  • Dogo Argentino
  • French Bulldog
  • Miniature Bull Terrier
  • Olde English Bulldogge
  • Staffordshire Bull Terrier
  • Staffordshire Terrier

Join the waitlist

How it works

If you’ve already tested with Embark's Breed ID or Breed + Health test, there’s no need to swab your dog again!

Here's how it works:

  • Sign up below and we’ll email you when the test is available for purchase.
  • After you complete your order, we’ll analyze your dog’s data and send you results within ~48 hours.
  • You’ll see your dog’s MCT risk in their Embark profile, plus helpful tips about how to use this information.
Shopping in the {{ userRegion }}?

You're viewing our {{ region }} website, but it looks like you're in the {{ userRegion }}.

Visit {{ market }} site